Nerve growth factor/p38 signaling increases intraepidermal nerve fiber densities in painful neuropathy of type 2 diabetes
- 31 January 2012
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 45 (1), 280-287
- https://doi.org/10.1016/j.nbd.2011.08.011
Abstract
No abstract availableKeywords
Funding Information
- Juvenile Diabetes Research Foundation Australia
- National Institutes of Health (1K08NS061039, 5P60 DK20572, UO1-DK60994)
- National Institute of Diabetes and Digestive and Kidney Diseases
This publication has 41 references indexed in Scilit:
- Measuring nerve regeneration in the mouseExperimental Neurology, 2010
- p38 Mediates Mechanical Allodynia in a Mouse Model of Type 2 DiabetesMolecular Pain, 2010
- Nerve Growth Factor Mediates Mechanical Allodynia in a Mouse Model of Type 2 DiabetesJournal of Neuropathology and Experimental Neurology, 2009
- Early loss of peptidergic intraepidermal nerve fibers in an STZ-induced mouse model of insensate diabetic neuropathyPain, 2008
- Characterization of myenteric neuropathy in the jejunum of spontaneously diabetic BB‐ratsNeurogastroenterology & Motility, 2008
- Neurotrophic modulation of myelinated cutaneous innervation and mechanical sensory loss in diabetic miceNeuroscience, 2006
- Do Pain Qualities and Spatial Characteristics Make Independent Contributions to Interference With Physical and Emotional Functioning?The Journal of Pain, 2006
- EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathyEuropean Journal of Neurology, 2005
- Phosphorylation of paxillin by p38MAPK is involved in the neurite extension of PC-12 cellsThe Journal of cell biology, 2004
- Early increase precedes a depletion of VIP and PGP‐9.5 in the skin of insulin‐dependent diabetics—correlation between quantitative immunohistochemistry and clinical assessment of peripheral neuropathyThe Journal of Pathology, 1993